ATAI Life Sciences Closes $149.5M Public Offering with Full Over-Allotment—Funding to Drive Mental Health Pipeline into 2029
Market Chameleon (Tue, 21-Oct 7:08 AM)
ATAI’s $130 Million Public Offering Targets Acceleration of Phase 2 Clinical Pipeline
Market Chameleon (Fri, 17-Oct 7:11 AM)
